Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial chloride secretory channels and transporters are a functional group of membrane proteins that mediate the efflux of chloride ions across the apical membrane of epithelial cells, a process that provides the osmotic driving force for water secretion. The primary components of this system include the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Calcium-activated Chloride Channels (CaCCs) such as TMEM16A (Anoctamin-1), and the basolateral Sodium-Potassium-Chloride Cotransporter 1 (NKCC1). These proteins are vital for maintaining the hydration and pH of mucosal surfaces in the respiratory, gastrointestinal, and reproductive tracts, as well as in exocrine glands. Dysregulation of these channels is a hallmark of several diseases; for instance, loss-of-function mutations in CFTR cause cystic fibrosis, while overactivation of these pathways by bacterial toxins leads to severe secretory diarrhea. Therapeutic strategies involve using small-molecule modulators to either restore channel activity in obstructive diseases or inhibit secretion in diarrheal and polycystic kidney diseases.
Drugs targeting these proteins modulate the transepithelial movement of chloride ions to regulate fluid secretion. CFTR modulators (correctors and potentiators) restore function to defective CFTR channels in cystic fibrosis by improving protein folding or channel gating. Agonists of ClC-2 or indirect activators of CFTR (via guanylate cyclase-C and cGMP) promote intestinal fluid secretion to treat chronic constipation. Conversely, inhibitors of CFTR and calcium-activated chloride channels (CaCCs) reduce excessive fluid loss in secretory diarrhea, while NKCC1 inhibitors block the basolateral chloride uptake required to sustain apical secretion.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial chloride secretory channels and transporters.